First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study
Background The combined use of immune checkpoint inhibitors (ICIs) with palliative chemotherapy (PCT) is a promising first-line treatment for de novo metastatic nasopharyngeal carcinoma (mNPC). However, the efficacy of ICIs with PCT vs PCT with definitive radiation therapy (DRT) remain unclear. Meth...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-08-01
|
| Series: | Cancer Control |
| Online Access: | https://doi.org/10.1177/10732748221124868 |